JAG1 and B-cell chronic lymphocytic leukemia: Next, CLL cells were pretreated for 2 h with the PI3Kδ inhibitor Idelalisib or DMSO as control, and then incubated for additional 24 h with IL-4 before analysis of Jag1 protein.